Zurcher Kantonalbank (Zurich Cantonalbank) Relay Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 28,697 shares of RLAY stock, worth $175,338. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,697
Previous 28,697
-0.0%
Holding current value
$175,338
Previous $75,000
32.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RLAY
# of Institutions
214Shares Held
173MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$170 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$82.2 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$81.6 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$69.6 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$64.4 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $735M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...